Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA, Ilg AM, Veruttipong D, Tan HJ, Burke MA, Niedzwiecki DR, Kupelian PA, King CR, Steinberg ML, Kundavaram CR, Kamrava M, Kaplan AL, Moriarity AK, Hsu W, Margolis DJ, Hu JC, Saigal CS.
Laviana AA, et al.
Cancer. 2016 Feb 1;122(3):447-55. doi: 10.1002/cncr.29743. Epub 2015 Nov 2.
Cancer. 2016.
PMID: 26524087
Free article.